Jazz Pharma awards 1,605 shares to director

McSharry Heather Ann reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

McSharry Heather Ann reported acquisition or exercise transactions in this Form 4 filing.

Jazz Pharmaceuticals director Heather Ann McSharry received a grant of 1,605 restricted stock units representing contingent rights to ordinary shares. The award was issued under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan and will vest in full on July 23, 2027, subject to continuous service and certain conditions. Following this grant, McSharry is reported to hold 20,054 ordinary shares directly.

Insider Trade Summary

Grant/Award: 1,605 shares

Grant/Award 1 txn

Insider McSharry Heather Ann

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1	1,605	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 20,054 shares (Direct)

Footnotes (1)

1. F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

Key Figures

RSUs granted: 1605.0000 shares Shares held after grant: 20054.0000 shares Vesting date: July 23, 2027 +1 more

4 metrics

RSUs granted 1605.0000 shares Restricted stock units awarded to director Heather Ann McSharry on 2026-08-05

Shares held after grant 20054.0000 shares Ordinary shares directly owned by Heather Ann McSharry following the transaction

Vesting date July 23, 2027 Date on which the granted restricted stock units vest in full, subject to conditions

Plan year 2007 Year of Jazz Pharmaceuticals’ Amended and Restated Non-Employee Directors Stock Award Plan

Key Terms

restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan

4 terms

restricted stock units financial

"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit."

continuous service financial

"Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."

Non-Employee Directors Stock Award Plan financial

"granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Heather Ann McSharry?

Heather Ann McSharry, a director of Jazz Pharmaceuticals, received a grant of 1,605 restricted stock units. Each unit represents a contingent right to one ordinary share, awarded as part of the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan.

When do Heather Ann McSharry’s new Jazz (JAZZ) restricted stock units vest?

The 1,605 restricted stock units granted to Heather Ann McSharry will vest in full on July 23, 2027. Vesting is conditioned on her continuous service as a non-employee director and certain additional plan conditions described by Jazz Pharmaceuticals.

How many Jazz Pharmaceuticals (JAZZ) shares does Heather Ann McSharry hold after this grant?

After the reported grant, Heather Ann McSharry is shown as directly holding 20,054 ordinary shares of Jazz Pharmaceuticals. This figure reflects her reported direct ownership position immediately following the award of 1,605 restricted stock units.

What type of equity award did Jazz Pharmaceuticals (JAZZ) grant to Heather Ann McSharry?

Jazz Pharmaceuticals granted Heather Ann McSharry restricted stock units (RSUs) under its 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each RSU is a contingent right to receive one ordinary share upon vesting, rather than an immediate share issuance.

Was Heather Ann McSharry’s Jazz (JAZZ) equity grant made under a 10b5-1 trading plan?

The transaction is reported as an equity grant with no indication that it was executed under a Rule 10b5-1 trading plan. The filing-level 10b5-1 checkbox is shown as unchecked, and the footnote describes the award only as a director stock plan grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 05:39 PM Accepted by SEC EDGAR 08/07/2026 - 05:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McSharry Heather Ann

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/05/2026		A(1)		1,605	A	$0.0	20,054	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.

	By: /s/Paz Dizon, as attorney in fact For: Heather Ann McSharry	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)